James Man Git Tsui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James Man Git Tsui has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Christopher C. Pack
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
3 shared publications- Tamim Niazi
Department of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, Canada
3 shared publications - Ahmad Chaddad
Guilin University of Electronic Technology
2 shared publications Boris Bahoric
Department of Radiation Oncology, Jewish General Hospital, Montreal, QC, Canada
2 shared publications- Christopher C. Pack
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
2 shared publications Farhan A. Khawaja
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
2 shared publications
Latest Publications
- Open Access
- 7 July 2026
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 9 (4)
Assessing the effect of race on machine learning models predicting hospital admissions from emergency department
Objectives: Machine learning (ML) models are increasingly being developed to support healthcare delivery. However, concerns remain about their potential to perpetuate existing biases rooted in the data used to develop them. We aim to assess the impact of using race in predicting hospital admission probabilities for patients visiting the emergency department (ED). Materials and Methods: Data from the MIMIC-IV ED dataset were used to train2 ML models predicting hospital admission: one included race; the other did not. Differences in predicted admission probabilities were evaluated across racial groups under multiple validation conditions. Results: Including race as a model input was associated with meaningful differences in predicted admission probabilities for White (3.2%), Black (−1.5%), and Hispanic (−3.0%) patients, while minimal differences were observed for Asian (0.2%) and Other (0.5%) patients. These differences were associated with large Cohen’s d effect sizes in the baseline model for White (d = 1.00), Black (d = −1.23), and Hispanic (d = −1.35) patients. After balancing racial group prevalence, the effects persisted for White (1.22%; d = 1.22) and Hispanic (−1.00%; d = −1.00) patients. Discussion: These findings suggest that race is associated with differences in ML-based hospital admission predictions for ED patients, underscoring the need for caution when incorporating race into clinical prediction models and the importance of rigorous bias assessment. Conclusion: As race was associated with predictions, there is a crucial need to address underlying social factors and the use of broader, more equitable clinical data for ML model training.
- 7 July 2026
- Published by Oxford University Press (OUP) in JAMIA Open
- Vol. 9 (4)
Open AccessAssessing the effect of race on machine learning models predicting hospital admissions from emergency department
Objectives: Machine learning (ML) models are increasingly being developed to support healthcare delivery. However, concerns remain about their potential to perpetuate existing biases rooted in the data used to develop them. We aim to assess the impact of using race in predicting hospital admission probabilities for patients visiting the emergency department (ED). Materials and Methods: Data from the MIMIC-IV ED dataset were used to train2 ML models predicting hospital admission: one included race; the other did not. Differences in predicted admission probabilities were evaluated across racial groups under multiple validation conditions. Results: Including race as a model input was associated with meaningful differences in predicted admission probabilities for White (3.2%), Black (−1.5%), and Hispanic (−3.0%) patients, while minimal differences were observed for Asian (0.2%) and Other (0.5%) patients. These differences were associated with large Cohen’s d effect sizes in the baseline model for White (d = 1.00), Black (d = −1.23), and Hispanic (d = −1.35) patients. After balancing racial group prevalence, the effects persisted for White (1.22%; d = 1.22) and Hispanic (−1.00%; d = −1.00) patients. Discussion: These findings suggest that race is associated with differences in ML-based hospital admission predictions for ED patients, underscoring the need for caution when incorporating race into clinical prediction models and the importance of rigorous bias assessment. Conclusion: As race was associated with predictions, there is a crucial need to address underlying social factors and the use of broader, more equitable clinical data for ML model training.
- Open Access
- 23 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105858
Retrospective patient-specific intravascular brachytherapy dosimetry using optical coherence tomography imaging
- 23 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105858
Open AccessRetrospective patient-specific intravascular brachytherapy dosimetry using optical coherence tomography imaging
- 20 October 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 218, 111211
Patterns of relapse and outcomes following Single-Fraction High-Dose-Rate brachytherapy monotherapy for Intermediate-Risk prostate cancer
- 20 October 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 218, 111211
Patterns of relapse and outcomes following Single-Fraction High-Dose-Rate brachytherapy monotherapy for Intermediate-Risk prostate cancer
- Open Access
The Silent Author in Urology: Quantifying Large Language Model Influence at the Corpus Level
Introduction: The recent increasing use of large language models (LLMs) such as ChatGPT in scientific writing raises concerns about authenticity and accuracy in biomedical literature. This study aims to quantify the prevalence of Artificial Intelligence (AI)-generated text in urology abstracts from 2010 to 2024 and assess its variation across journal categories and impact factor quartiles. Methods: A retrospective analysis was conducted on 64,444 unique abstracts from 38 journals in the field of urology published between 2010-2024 and retrieved via the Entrez API from PubMed. Abstracts were then categorized by subspecialty and stratified by impact factor (IF). A synthetic reference corpus of 10,000 abstracts was generated using GPT-3.5-turbo. A mixture model estimated the proportion of AI-generated text annually, using maximum likelihood estimation with Laplace smoothing. Calibration and specificity of the estimator were assessed using pre-LLM abstracts and controlled mixtures of real and synthetic text. Statistical analyses were performed using Python 3.13. Results: The proportion of AI-like text was negligible from 2010 to 2019, rising to 1.8% in 2020 and 5.3% in 2024. In 2024, Men’s Health journals showed the highest AI-like text, while Oncology journals had the lowest. Journals in the highest and lowest IF quartiles showed a higher proportion of AI-like text than mid-quartiles. Type-Token Ratio (TTR) remained stable across the study period. Our validation calibration set showed an area under the curve of 0.5326. Conclusion: Textual patterns similar to AI-generated language has risen sharply in urology abstracts since ChatGPT’s release in late 2022, and this trend varies by journal type and IF. Patient summary: We looked at whether large language models (LLM) such as ChatGPT are influencing the way urology research is written. We found that signs of LLM-like text were rare in abstracts before 2020 but increased in recent years, especially after the release of ChatGPT. Some journal types use these tools more than others. These findings help raise awareness about the growing role of artificial intelligence in scientific communication.
Open AccessThe Silent Author in Urology: Quantifying Large Language Model Influence at the Corpus Level
Introduction: The recent increasing use of large language models (LLMs) such as ChatGPT in scientific writing raises concerns about authenticity and accuracy in biomedical literature. This study aims to quantify the prevalence of Artificial Intelligence (AI)-generated text in urology abstracts from 2010 to 2024 and assess its variation across journal categories and impact factor quartiles. Methods: A retrospective analysis was conducted on 64,444 unique abstracts from 38 journals in the field of urology published between 2010-2024 and retrieved via the Entrez API from PubMed. Abstracts were then categorized by subspecialty and stratified by impact factor (IF). A synthetic reference corpus of 10,000 abstracts was generated using GPT-3.5-turbo. A mixture model estimated the proportion of AI-generated text annually, using maximum likelihood estimation with Laplace smoothing. Calibration and specificity of the estimator were assessed using pre-LLM abstracts and controlled mixtures of real and synthetic text. Statistical analyses were performed using Python 3.13. Results: The proportion of AI-like text was negligible from 2010 to 2019, rising to 1.8% in 2020 and 5.3% in 2024. In 2024, Men’s Health journals showed the highest AI-like text, while Oncology journals had the lowest. Journals in the highest and lowest IF quartiles showed a higher proportion of AI-like text than mid-quartiles. Type-Token Ratio (TTR) remained stable across the study period. Our validation calibration set showed an area under the curve of 0.5326. Conclusion: Textual patterns similar to AI-generated language has risen sharply in urology abstracts since ChatGPT’s release in late 2022, and this trend varies by journal type and IF. Patient summary: We looked at whether large language models (LLM) such as ChatGPT are influencing the way urology research is written. We found that signs of LLM-like text were rare in abstracts before 2020 but increased in recent years, especially after the release of ChatGPT. Some journal types use these tools more than others. These findings help raise awareness about the growing role of artificial intelligence in scientific communication.
- 23 March 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 207, 110866
Evaluating the prognostic significance of artificial intelligence-delineated gross tumor volume and prostate volume measurements for prostate radiotherapy
- 23 March 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 207, 110866
Evaluating the prognostic significance of artificial intelligence-delineated gross tumor volume and prostate volume measurements for prostate radiotherapy
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e240041
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer
The volume of artificial intelligence–segmented intraprostatic tumors was an independent prognostic factor for outcomes of localized prostate cancer treated with radical prostatectomy and radiation therapy.
- 1 October 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (1) , e240041
AI-derived Tumor Volume from Multiparametric MRI and Outcomes in Localized Prostate Cancer
The volume of artificial intelligence–segmented intraprostatic tumors was an independent prognostic factor for outcomes of localized prostate cancer treated with radical prostatectomy and radiation therapy.
- 14 July 2021
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 162, 156-161
Extreme weekly locoregional hypofractionated radiation in elderly women with non-metastatic breast cancer
- 14 July 2021
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 162, 156-161
Extreme weekly locoregional hypofractionated radiation in elderly women with non-metastatic breast cancer
- Open Access
- 12 March 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 312
Combined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study
Purpose: Following radical prostatectomy, prostate bed radiotherapy (PBRT) has been combined with either long-term androgen deprivation therapy (LT-ADT) or short-term ADT with pelvic lymph node radiotherapy (PLNRT) to provide an oncological benefit in randomized trials. McGill 0913 was designed to characterize the efficacy of combining PBRT, PLNRT, and LT-ADT. It is the first study to do so prospectively. Methods: In a single arm phase II trial conduced from 2010 to 2016, 46 post-prostatectomy prostate cancer patients at a high-risk for relapse (pathological Gleason 8+ or T3) were assessed for treatment with combined LT-ADT (24 months), PBRT, and PLNRT. Patients received PLNRT and PBRT (44 Gy in 22 fractions) followed by a PBRT boost (22 Gy in 11 fractions). The primary endpoint was progression-free survival (PFS). Toxicity and quality of life (QoL) were evaluated using CTCAE V3.0 and EQ-5D-3L questionnaires, respectively. Results: Among the 43 patients were treated as per protocol, median PSA was 0.30 μg/L. On surgical pathology, 51% had positive margins, 40% had Gleason 8+ disease, 42% had seminal vesicle involvement, and 19% had lymph node involvement. At a median follow-up of 5.2 years, there were no deaths or clinical progression. At 5 years, PFS was 78.0% (95% Confidence Interval 63.7–95.5%). Not including erectile dysfunction, patients experienced: 14% grade 2 endocrine toxicity while on ADT, one incident of long-term gynecomastia, 5% grade 2 acute urinary toxicity, 5% grade 2 late Urinary toxicity, and 24% long-term hypogonadism. No comparison between the average or minimum self-reported QoL at baseline, during ADT, nor after ADT demonstrated a statistically significant difference. Conclusions: Combining PBRT, PLNRT, and LT-ADT had an acceptable PFS in patients with significant post-operative risk factors for recurrence. While therapy was well-tolerated, long-term hypogonadism was a substantial risk. Further investigations are needed to determine if this combination is beneficial. Trial registration: NCT01255891.
- 12 March 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 312
Open AccessCombined Long-Term Androgen Deprivation and Pelvic Radiotherapy in the Post-operative Management of Pathologically Defined High-Risk Prostate Cancer Patients: Results of the Prospective Phase II McGill 0913 Study
Purpose: Following radical prostatectomy, prostate bed radiotherapy (PBRT) has been combined with either long-term androgen deprivation therapy (LT-ADT) or short-term ADT with pelvic lymph node radiotherapy (PLNRT) to provide an oncological benefit in randomized trials. McGill 0913 was designed to characterize the efficacy of combining PBRT, PLNRT, and LT-ADT. It is the first study to do so prospectively. Methods: In a single arm phase II trial conduced from 2010 to 2016, 46 post-prostatectomy prostate cancer patients at a high-risk for relapse (pathological Gleason 8+ or T3) were assessed for treatment with combined LT-ADT (24 months), PBRT, and PLNRT. Patients received PLNRT and PBRT (44 Gy in 22 fractions) followed by a PBRT boost (22 Gy in 11 fractions). The primary endpoint was progression-free survival (PFS). Toxicity and quality of life (QoL) were evaluated using CTCAE V3.0 and EQ-5D-3L questionnaires, respectively. Results: Among the 43 patients were treated as per protocol, median PSA was 0.30 μg/L. On surgical pathology, 51% had positive margins, 40% had Gleason 8+ disease, 42% had seminal vesicle involvement, and 19% had lymph node involvement. At a median follow-up of 5.2 years, there were no deaths or clinical progression. At 5 years, PFS was 78.0% (95% Confidence Interval 63.7–95.5%). Not including erectile dysfunction, patients experienced: 14% grade 2 endocrine toxicity while on ADT, one incident of long-term gynecomastia, 5% grade 2 acute urinary toxicity, 5% grade 2 late Urinary toxicity, and 24% long-term hypogonadism. No comparison between the average or minimum self-reported QoL at baseline, during ADT, nor after ADT demonstrated a statistically significant difference. Conclusions: Combining PBRT, PLNRT, and LT-ADT had an acceptable PFS in patients with significant post-operative risk factors for recurrence. While therapy was well-tolerated, long-term hypogonadism was a substantial risk. Further investigations are needed to determine if this combination is beneficial. Trial registration: NCT01255891.
- 2 April 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 104 (4) , 773-777
Tumor Board Shadowing: A Unique Approach for Integrating Radiation Oncologists Into General Medical Student Education
- 2 April 2019
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 104 (4) , 773-777
Tumor Board Shadowing: A Unique Approach for Integrating Radiation Oncologists Into General Medical Student Education
- Open Access
- 1 January 2019
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 18
Does Interfraction Cone Beam Computed Tomography Improve Target Localization in Prostate Bed Radiotherapy?
In this prospective phase II study, we investigated whether cone beam computed tomography scan was a superior method of image-guided radiotherapy relative to 2D orthogonal kilovoltage images in the post-radical prostatectomy setting. A total of 419 treatment fractions were included in this analysis. The shifts required to align the patient for each treatment were performed using 3D matching between cone beam computed tomography scans and the corresponding computed tomography images used for planning. This was compared with the shifts obtained from 2D orthogonal kilovoltage images, matching with the corresponding digitally reconstructed radiographs. Patients did not have fiducials inserted to assist with localization. Interfractional changes in the bladder and rectal volumes were subsequently measured on the cone beam computed tomography images for each fraction and compared to the shift differences between orthogonal kilovoltage and cone beam computed tomography scans. The proportion of treatment fractions with a shift difference exceeding the planning target volume of 7 mm, between orthogonal kilovoltage and cone beam computed tomography scans, was calculated. The mean vertical, lateral, and longitudinal shifts resulted from 2D match between orthogonal kilovoltage images and corresponding digitally reconstructed radiographs were 0.353 cm (interquartile range: 0.1-0.5), 0.346 cm (interquartile range: 0.1-0.5), and 0.289 cm (interquartile range: 0.1-0.4), compared to 0.388 cm (interquartile range: 0.1-0.5), 0.342 cm (interquartile range: 0.1-0.5), and 0.291 cm (interquartile range: 0.1-0.4) obtained from 3D match between cone beam computed tomography and planning computed tomography scan, respectively. Our results show a significant difference between the kilovoltage and cone beam computed tomography shifts in the anterior–posterior direction (P = .01). The proportion of treatment fractions in which the differences in kilovoltage and cone beam computed tomography shifts between exceeded the 7 mm planning target volume margin was 6%, 2%, and 3% in the anterior–posterior, lateral, and superior–inferior directions, respectively. We prospectively demonstrated that the daily use of volumetric cone beam computed tomography for treatment localization in post-radical prostatectomy patients demonstrated an increased need for a shift in patient position. This suggests that in post-radical prostatectomy patients the daily cone beam computed tomography imaging improved localization of the prostate bed and may have prevented a limited number of geographic misses, compared to daily kilovoltage imaging that was not assisted with fiducials.
- 1 January 2019
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 18
Open AccessDoes Interfraction Cone Beam Computed Tomography Improve Target Localization in Prostate Bed Radiotherapy?
In this prospective phase II study, we investigated whether cone beam computed tomography scan was a superior method of image-guided radiotherapy relative to 2D orthogonal kilovoltage images in the post-radical prostatectomy setting. A total of 419 treatment fractions were included in this analysis. The shifts required to align the patient for each treatment were performed using 3D matching between cone beam computed tomography scans and the corresponding computed tomography images used for planning. This was compared with the shifts obtained from 2D orthogonal kilovoltage images, matching with the corresponding digitally reconstructed radiographs. Patients did not have fiducials inserted to assist with localization. Interfractional changes in the bladder and rectal volumes were subsequently measured on the cone beam computed tomography images for each fraction and compared to the shift differences between orthogonal kilovoltage and cone beam computed tomography scans. The proportion of treatment fractions with a shift difference exceeding the planning target volume of 7 mm, between orthogonal kilovoltage and cone beam computed tomography scans, was calculated. The mean vertical, lateral, and longitudinal shifts resulted from 2D match between orthogonal kilovoltage images and corresponding digitally reconstructed radiographs were 0.353 cm (interquartile range: 0.1-0.5), 0.346 cm (interquartile range: 0.1-0.5), and 0.289 cm (interquartile range: 0.1-0.4), compared to 0.388 cm (interquartile range: 0.1-0.5), 0.342 cm (interquartile range: 0.1-0.5), and 0.291 cm (interquartile range: 0.1-0.4) obtained from 3D match between cone beam computed tomography and planning computed tomography scan, respectively. Our results show a significant difference between the kilovoltage and cone beam computed tomography shifts in the anterior–posterior direction (P = .01). The proportion of treatment fractions in which the differences in kilovoltage and cone beam computed tomography shifts between exceeded the 7 mm planning target volume margin was 6%, 2%, and 3% in the anterior–posterior, lateral, and superior–inferior directions, respectively. We prospectively demonstrated that the daily use of volumetric cone beam computed tomography for treatment localization in post-radical prostatectomy patients demonstrated an increased need for a shift in patient position. This suggests that in post-radical prostatectomy patients the daily cone beam computed tomography imaging improved localization of the prostate bed and may have prevented a limited number of geographic misses, compared to daily kilovoltage imaging that was not assisted with fiducials.